Abstract
Copper complexes with fluorinated β-diketones were synthesized and characterized in terms of lipophilicity and peroxide-assisted oxidation of dihydrorhodamine as an indicator of redox activity. The biological activity of the complexes was tested against promastigotes of Leishmania amazonensis. Inhibition of trypanosomatid-specific trypanothione reductase was also tested. It was found that the highly lipophilic and redox-active bis(trifluoroacetylacetonate) derivative had increased toxicity towards promastigotes. These results indicate that it is possible to modulate the activity of metallodrugs based on redox-active metals through the appropriate choice of lipophilic chelators in order to design new antileishmanials. Further work will be necessary to improve selectivity of these compounds against the parasite.
Similar content being viewed by others
References
Cruz AK, de Toledo JS, Falade M, Terrao MC, Kamchonwongpaisan S, Kyle DE, Uthaipibull C (2009) Curr Drug Targets 10:178–192
Fricker SP (2010) Metallomics 2:366–377
Mukhopadhyay R, Beitz E (2010) In: Mips and their role in the exchange of metalloids, pp 57–70
Lima AKC, Elias CGR, Souza JEO, Santos ALS, Dutra PML (2009) Parasitology 136:1179–1191
Vieites M, Smircich P, Parajon-Costa B, Rodriguez J, Galaz V, Olea-Azar C, Otero L, Aguirre G, Cerecetto H, Gonzalez M, Gomez-Barrio A, Garat B, Gambino D (2008) J Biol Inorg Chem 13:723–735
Baiocco P, Colotti G, Franceschini S, Ilari A (2009) J Med Chem 52:2603–2612
Wyllie S, Cunningham ML, Fairlamb AH (2004) J Biol Chem 279:39925–39932
Cunningham ML, Fairlamb AH (1995) Eur J Biochem 230:460–468
Castro-Pinto DB, Genestra M, Menezes GB, Waghabi M, Gonçalves A, Del Cristia CN, Sant’Anna CMR, Leon LL, Mendonça-Lima L (2008) Arch Microbiol 189:375–384
Fairlamb AH, Cerami A (1985) Mol Biochem Parasitol 14:187–198
Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A (1985) Science 227:1485–1487
Overbeck S, Rink L, Haase H (2008) Arch Immunol Ther Exp 56:15–30
Jacques I, Andrews NW, Huynh C (2010) Mol Biochem Parasitol 170:28–36
Sen G, Mukhopadhyay S, Ray M, Biswas T (2008) J Antimicrob Chemother 61:1066–1075
Fricker SP, Mosi RM, Cameron BR, Baird I, Zhu YB, Anastassov V, Cox J, Doyle PS, Hansell E, Lau G, Langille J, Olsen M, Qin L, Skerlj R, Wong RSY, Santucci Z, McKerrow JH (2008) J Inorg Biochem 102:1839–1845
Soares MBP, Costa JFO, de Sa MS, Ribeiro-Dos-Santos R, Pigeon P, Jaouen G, Santana AEG, Goulart MOF, Hillard E (2010) Drug Dev Res 71:69–75
Navarro M, Cisneros-Fajardo EJ, Sierralta A, Fernandez-Mestre M, Silva P, Arrieche D, Marchan E (2003) J Biol Inorg Biochem 8:401–408
Navarro M (2009) Coord Chem Rev 253:1619–1626
Navarro M, Hernandez C, Colmenares I, Hernandez P, Fernandez M, Sierraalta A, Marchan E (2007) J Inorg Biochem 101:111–116
Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R (2009) Crit Rev Ther Drug Carrier Syst 26:523–580
Eroy-Reveles AA, Mascharak PK (2009) Future Med Chem 1:1497–1507
Genestra M, Soares-Bezerra RJ, Gomes-Silva L, Fabrino DL, Bellato-Santos T, Castro-Pinto DB, Canto-Cavalheiro MM, Leon LL (2008) Cell Biochem Funct 26:709–717
Maffei RD, Yokoyama-Yasunaka JKU, Miguel DC, Uliana SRB, Esposito BP (2009) Biometals 22:1095–1101
Hummadi Y, Najim RA, Al-Bashir NM (2005) Exp Parasitol 111:47–54
Dea-Ayuela MA, Castillo E, Gonzalez-Alvarez M, Vega C, Rolon M, Bolas-Fernandez F, Borras J, Gonzalez-Rosende ME (2009) Bioorg Med Chem 17:7449–7456
Namazi MR (2008) Ind J Med Res 127:193–194
Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Oxford University Press, Oxford
Frelon S, Douki T, Favier A, Cadet J (2003) Chem Res Toxicol 16:191–197
Mylonas M, Malandrinos G, Plakatouras J, Hadjiliadis N, Kasprzak KS, Krezel A, Bal W (2001) Chem Res Toxicol 14:1177–1183
Ogasawara MA, Zhang H (2009) Antioxid Redox Signal 11:1107–1122
Gius D, Mattson D, Bradbury CM, Smart DK, Spitz DR (2004) Int J Hyperthermia 20:213–223
Decaudin D, Marzo I, Brenner C, Kroemer G (1998) Int J Oncol 12:141–152
Ge Y, Byun JS, De Luca P, Gueron G, Yabe IM, Sadiq-Ali SG, Figg WD, Quintero J, Haggerty CM, Li QQ, De Siervi A, Gardner K (2008) Mol Pharmacol 74:872–883
Belford RL, Martell AE, Calvin M (1956) J Inorg Nucl Chem 2:11–31
Harju L, Sara R (1974) Anal Chim Acta 73:129–139
Dearden J, Bresnen G (1988) Quant Struct Act Relat 7:133–144
Esposito BP, Breuer W, Slotki I, Cabantchik ZI (2002) Eur J Clin Invest 32:42–49
Hamilton CJ, Saravanamuthu A, Eggleston IM, Fairlamb AH (2003) Biochem J 369:529–537
Miguel DC, Yokoyama-Yasunaka JKU, Andreoli WK, Mortara RA, Uliana SRB (2007) J Antimicrob Chemother 60:526–534
Maverick AW, Fronczek FR, Maverick EF, Billodeaux DR, Cygan ZT, Isovitsch RA (2002) Inorg Chem 41:6488–6492
Baosic R, Radojevic A, Radulovic M, Miletic S, Natic M, Tesic Z (2008) Biomed Chromatogr 22:379–386
Chohan ZH, Arif M, Akhtar MA, Supuran CT (2006) Bioinorg Chem Appl
Baum L, Ng A (2004) J Alzheimers Dis 6:367–377
Maurya RC, Verma R, Singh H (2003) Synth React Inorg Met Org Chem 33:1063–1080
Giri U, Iqbal M, Athar M (1999) Int J Oncol 14:799–806
White VE, Knowles CJ (2003) Int Biodeterior Biodegrad 52:143–150
Keen CL, Saltman P, Hurley LS (1980) Am J Clin Nutr 33:1789–1800
Esposito BP, Faljoni-Alario A, de Menezes JFS, de Brito HF, Najjar R (1999) J Inorg Biochem 75:55–61
Calvin M, Wilson W (1945) J Am Chem Soc 67:2003–2007
Martell AE, Smith RM (1974) Critical stability constants. Plenum Press, New York
Esposito BP (2007) Braz J Nutr 20:379–385
Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI (2003) Blood 102:2670–2677
Rangel EB, Esposito BP, Carneiro FD, Mallet AC, Matos ACC, Andreoli MCC, Guimaraes-Souza NK, Santos BFC (2010) Ther Apher Dial 14:186–192
Do Amaral S, Esposito BP (2008) Biometals 21:425–432
Silva SBL, Arndt A, Esposito BP (2010) J Water Res Prot 2:209–213
American Chemical Society (2007) SciFinder Scholar, version 2007. American Chemical Society, Washington
Benson TJ, McKie JH, Garforth J, Borges A, Fairlamb AH, Douglas KT (1992) Biochem J 286:9–11
Acknowledgments
Raúl Hernández helped us with the statistical analysis. This project was funded by CNPq and FAPESP (Brazilian government agencies).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Portas, A.d.S., Miguel, D.C., Yokoyama-Yasunaka, J.K.U. et al. Increasing the activity of copper(II) complexes against Leishmania through lipophilicity and pro-oxidant ability. J Biol Inorg Chem 17, 107–112 (2012). https://doi.org/10.1007/s00775-011-0834-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-011-0834-3